Patent · US Active

Treatment of a disease of the gastrointestinal tract with an IL-12/IL-23 inhibitor released using an ingestible device

US11597762B2 · kind B2 · utility

0Cited by
41References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 14, 2017
Grant dateMar 7, 2023
Priority date—
Expiry dateMar 12, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/11
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an IL-12/IL-23 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.